Abstract
Annexin A11 (ANXA11) is a calcium-dependent phospholipid-binding protein belonging to the annexin protein family and implicated in the neurodegenerative amyotrophic lateral sclerosis. Structurally, ANXA11 contains a conserved calcium-binding C-terminal domain common to all annexins and a putative intrinsically unfolded N-terminus specific for ANXA11. Little is known about the structure and functions of this region of the protein. By analogy with annexin A1, it was suggested that residues 38 to 59 within the ANXA11 N-terminus could form a helical region that would be involved in interactions. Interestingly, this region contains residues that, when mutated, may lead to clinical manifestations. In the present study, we have studied the structural features of the full-length protein with special attention to the N-terminal region using a combination of biophysical techniques which include nuclear magnetic resonance and small angle X-ray scattering. We show that the N-terminus is intrinsically disordered and that the overall features of the protein are not markedly affected by the presence of calcium. We also analyzed the 38–59 helix hypothesis using synthetic peptides spanning both the wild-type sequence and clinically relevant mutations. We show that the peptides have a remarkable character typical of a native helix and that mutations do not alter the behaviour suggesting that they are required for interactions rather than being structurally important. Our work paves the way to a more thorough understanding of the ANXA11 functions.
Introduction
The length of neurons, the main components of the nervous system, can range from less than a millimeter to over a meter in some cases. In some animals, such as certain species of whales, axons can be up to 30 m in length. However, whatever their lengths, neurons must sense and respond to stimuli and readily transfer signals to all their regions in the order of milliseconds. To fulfil this need, neurons rely on specialized machines that permit the synthesis of proteins locally and deliver mRNAs from the cell body to the different remote locations (). An elegantly regulated way to transport mRNA involves the formation of discrete RNA granules (), which are membraneless organelles that contain both RNA and RNA-binding protein aggregates (; ). Organelle transport inside the cells usually requires both the molecular motor proteins kinesin and dynein and microtubules that provide polarized tracks which, depending on the molecular motor, allow movement from/to the dendrites and the axon (). Any impairment of this information leads to neurodegenerative diseases, including Alzheimer disease and amyotrophic lateral sclerosis (ALS) (; ).
Recently, a novel mechanism, termed “hitchhiking,” was described, in which organelles can traffic along the microtubules not by directly interacting with the motors but by temporarily “hitchhiking” being bound to other organelles that are already moving and that act as “vehicles” to support the movement of other cargos (). This mechanism needs other molecules to act as a tether. One of the proteins that has been described as a molecular tether between RNA granules and lysosomes is annexin A11 (ANXA11) (). ANXA11 has also been linked to amyotrophic lateral sclerosis (ALS), an incurable progressive motor neuron disease. ALS has been associated to many different genes that encode RNA-binding proteins, mostly involved in RNA trafficking, that, when mutated, can lead to irreversible protein aggregation and disease (; ; ).
ANXA11 is a 56 kDa widely expressed protein, that belongs to the annexin protein family whose members play an important role in cell division, calcium signalling, vesicle trafficking and apoptosis (; ; ; ). Annexins are calcium-dependent proteins whose primary function is binding to phospholipids. In a recent elegant work, it was also conclusively shown that ANXA11 binds to RNA and that RNA-binding seems to be a common feature of the whole annexin family, suggesting a general role of these proteins in granule trafficking (). The annexin structure comprises a conserved C-terminal core domain that is formed by four helical repeats (annexin repeats) well distinct from other calcium-binding motifs (Scheme 1 and Supplementary Figure S1). Each annexin motif contains ∼70 amino acids and is arranged into five α-helices, termed A–E (). The loops connecting the AB and DE helical hairpins contain the Ca2+ binding sites, with helix C packed against the other components of the bundle orthogonally. Lipid binding involves the core domain and seems to be coupled, at least in some members of the family, to a conformational change induced by Ca2+ binding (). The core domain is preceded by a highly variable region both in sequence and N-terminus length that is thought to mediate interactions. The recent paper by the Vedeler’s group demonstrates that RNA-binding is mostly contributed by the C-terminus of ANXA11 although we do not know where or how, whereas the N-terminus has some minor role in modulating the interaction ().
The structure of the C-terminal domain of ANXA11 has been solved () and, as expected, superposes with the corresponding region of other annexins within 1.2 Å. The N-terminal domain of ANXA11 is ∼200 residues (one of the longer in the annexin family) and contains low complexity regions dominated by prolines which account for 1/3 of the residues. Several mutations were identified in a thorough screening of a large cohort of familial ALS patients in the non-conserved N-terminus, including the p.D40G and p.G38R variants in the N-terminus (; ). Although unique to ANXA11, the N-terminus contains a motif that is reminiscent of the N-terminus of annexin A1 (ANXA1) (). In this protein, residues 2–26 form a helix and fold back to pack against the core domain in the absence of calcium. Calcium binding causes a conformational rearrangement of the core domain and the release of the helix which becomes available for interactions with other proteins (; ; ). A similar mechanism of regulation was suggested for ANXA11, and a putative helical motif was identified around residues 38–59 (). It was also suggested that regulation of interactions with the apoptosis-linked gene-2 protein (ALG-2) and S100A6 (calcyclin) () occurs through a Ca2+-induced conformational rearrangement of the C-terminus that leads to release of the N-terminus, making it proficient for interaction with its partners (). These two interacting proteins seem to be potent regulators of ANXA11-based liquid-liquid phase separation which affects formation of ribonuclear granules (). This phenomenon is thought to be at the very basis of mRNA transport in neurons (; ). Accordingly, a ANXA11 p.D40G ALS-related mutation was proven experimentally to abolish calcyclin binding (), whereas no effect was observed with a p.G38R mutant. Despite this evidence, definite validation of the 38–59 helical hypothesis may only be achieved by solving the structure of full-length ANXA11.
In the present study, we used a hybrid approach based on a combination of spectroscopic methods and small-angle X-ray scattering (SAXS) to characterize the structure of full-length ANXA11. We proved that the N-terminal domain is intrinsically disordered and determined its relative orientation as compared to the C-terminal core domain in a calcium-dependent manner. We then structurally characterized synthetic peptides encompassing the sequence of the region 38–59 of wild-type and mutated ANXA11 and proved that they both adopt a helical structure. Finally, we used advanced computational tools (; ) to predict regions with RNA-binding properties and granule-forming tendencies. Our evidence fully supports the helix hypothesis and suggests a distinct and specific role of the N-terminal domain of ANXA11 in its tethering functions.
SCHEME 1
Materials and methods
Sample preparation
Four peptides were studied, spanning the sequence of the residues 38–61 of wild-type ANXA11 and mutated versions (WT, G38R, and D40G). The peptides were purchased from PEPCEUTICALS Ltd. (Leicester, United Kingdom). The molecular weights were validated by mass spectrometry.
ANXA11 expression and purification
The coding sequence for full-length human ANXA11 in the plasmid pMCSG7-MBP-ANXA11 was kindly sent by Boris Rogelj’s laboratory (Jožef Stefan Institute, Ljubljana, Slovenia). The ANXA11 N-terminus (residues 1–191) was donated by Salvatore Adinolfi (University of Turin, Italy) in a pET His6 TEV LIC plasmid with an N-terminal thioredoxin tag. The constructs were expressed in E. coli BL21 (DE3) cells.
Transformed cultures of the proteins were grown in Luria broth (LB) supplemented with 100 μg/mL ampicillin at 37°C until the optical density at 600 nm reached 0.6 and induced with 1 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) at 20°C. Cells were collected by centrifugation and resuspended in lysis buffer and lysed by sonication. The soluble proteins were recovered in the supernatant by centrifugation at 4°C, and purified by nickel affinity chromatography using 300 mM imidazole in the elution buffer. The tag of ANXA11 was cleaved by incubating the construct with tobacco etch virus protease (1:50 enzyme/protein) overnight at 4°C, while dialyzing the mixture in SEC buffer. Pure ANXA11 was obtained after a reverse Ni-NTA chromatography step, and a further size-exclusion chromatography step on an Äkta pure system (HiLoad 16/600 Superdex 200 column, GE Healthcare). Each purification step of the full-length protein was carried out at 4°C, at pH 8.5 in 20 mM Tris-HCl buffer, 150 mM KCl, and additional 5 mM EDTA and 1 mM DTT in the SEC buffer.
Pure ANXA11 N-terminus with an N-terminal Thioredoxin-(His)6 tag was obtained after a further step of size-exclusion chromatography on an ÄKTA Prime Plus system (HiLoad 26/600 Superdex 75 prep grade column, GE Healthcare). Attempts to purify the untagged ANXA11 N-terminus in 20 mM HEPES, 20 mM NaCl buffer at pH 7.0 without the Thioredoxin-(His)6 tag led to quantitative precipitation. Protein purity was assessed by SDS-PAGE (Supplementary Figure S2). Protein identity was validated by LC-MS/MS with 86% of sequence coverage. The proteins were aliquoted, flash-frozen and stored at −80°C. 15N-labelled samples were obtained by growing the cells in minimal media using 15N ammonium sulphate as the sole source of ammonium.
Spectroscopic measurements
Far-Ultraviolet (UV) CD spectra were recorded on a JASCO-1100 spectropolarimeter equipped with a temperature control system, averaged over 10 scans and deconvoluted with the online analysis software K2D3 and BestSel. Measurements were carried out in 1 mm path-length quartz cuvettes (type S3/Q/1; Starna Scientific), applying a constant N2 flush at 4.0 L/min.
NMR measurements were carried out on 200 µM non-labelled peptides in a 10 mM sodium phosphate buffer, at pH 6.8 and on 100 µM 15N-labelled Thioredoxin-tagged ANXA11 N-terminus sample in 20 mM HEPES, 20 mM NaCl buffer at pH 7.0. D2O (10%) was added to the samples. NMR spectra were recorded on Bruker 800 spectrometers at 5°C and at 25°C, respectively, and processed with NMRPipe (). Spectra were analyzed and assigned with NMR-Fam Sparky () and CARA 1.9.1.7 (). TOCSY spectra were measured using the ‘dipsi2esfbgpph’ pulse sequence. NOESY spectra were recorded with a mixing time of 250 ms. Both experiments and COSY spectra (cosydfesgpphpp) were recorded with 4,096 data points in t2 and 1,024 data points in t1. For the assignment of the Thioredoxin tag a set of three spectra were recorded: 1H-15N HSQC (hsqcfpf3gpphwg_f1180), TOCSY-HSQC (dipsihsqcf3gpwg3d) and NOESY-HSQC (noesyhsqcf3gpwg3d_cpds).
Molecular dynamics simulations
The standard iterative protocol was used with the ARIAweb 07d7d10a (2021-06-08) service (; ) on the Pasteur@Galaxy cluster (doi 10.7490/f1000research.1114334.1) using default settings. ARIAweb implements the latest release of ARIA version 2.3 () in combination with CNS version 1.21 () modified with dedicated ARIA routines. 143 NOE based distance restraints were used (75 intra-residue and 68 sequential). The number of structures calculated was twenty for iterations 0–8 of which the seven best - based on the total energy - were used in the proceeding iteration. After nine iterations were completed, the 10 lowest energy conformers were refined in a shell of water molecules.
Further Molecular dynamics (MD) simulations were performed using the NAMD 2.13 package () with the CHARMM36m force field. Input files were generated with CHARMM-GUI (; ). The structures were solvated with the TIP3P water model in a rectangular box such that the minimum distance to the edge of the box was 10 Å under periodic boundary conditions. An appropriate number of Na+ counterions were added to neutralize the protein charge. The replicas were used for three separate production runs: ii) one imposing all NOE restraints, ii) one imposing only NH-NH NOE restraints, and iii) one with no restraints. For all active restraints the lower and upper walls were defined below and above 2.5 and 5.5 Å, with constants of 2 and 10 kcal mol−1 Å−2 respectively. Each replica was subject to 1 ns of equilibration at 278.1 K and normal pressure. The production runs (100 ns) were performed under the same conditions.
The structure evaluation and analysis procedures were performed with NMRBox (). Ten thousand structures were generated.
Computer-assisted predictions
Structure predictions were carried out either running AlphaFold 2.2.0 in NMRBox (https://nmrbox.nmrhub.org/) or running the prediction on the Baker’s lab Robetta server (https://robetta.bakerlab.org/results.php?id=550799) using the full-length protein. Per-residue estimates of the confidence of the models for the AlphaFold models are given by per-residue predicted local distance difference test (pLDDT) scores of the final model. This score is a scale 0–100 and represents the confidence of the predicted structure compared to the “true” (ground truth) structure. Likewise, confidence in RosETTAFold models is given by the global distance test (GDT) (100.0 good, 0.0 bad). The structures were visualized using Pymol (Schrödinger, L. & DeLano, W. (2020), retrieved from http://www.pymol.org/pymol).
Structure predictions of the peptides based on chemical shift information was achieved by CS-Rosetta (https://csrosetta.chemistry.ucsc.edu/) (). CS-Rosetta produces reliable structural ensembles from NMR observables (chemical shifts, J-couplings, NOEs, residual dipolar couplings, etc.). To do this, it performs a selection of protein backbone fragments from high-resolution structures from the PDB, which are used in conjunction with Rosetta’s high-resolution energy function to model the structures of proteins up to 35 kDa.
The catGRANULE software (http://service.tartaglialab.com/new_submission/catGRANULE) was used to predict the protein tendency to phase separate (). catRAPID signature was used to predict the propensity of TDP-43 to interact with RNA and identify RNA-binding domains ().
SAXS measurements
SAXS experiments were performed at the BM29 beamline at the ESRF in Grenoble, France (). The wavelength of the beamline was 0.99 Å (12.5 KeV), with the distance between sample and detector (PILATUS3 2M) set to 2,812 mm, giving the scattering vector q 0.007–0.55 Å−1. This vector is defined as q = 4π sin(θ)/λ, where 2θ is the scattering angle and λ is the wavelength of the incident beam. Ten successive frames of the scattering from the samples were recorded in batch mode with an exposure time of 2 s for each frame due to 75 mA beam intensity. The scattering from the corresponding buffer was measured before and after each sample for the same exposure time, and subtracted from the sample scattering. Measurements were performed at 20°C, and the forward scattering, I0, was converted to an absolute scale by water calibration. The data were automatically reduced using FreeSAS () and further processed and analyzed using the Scatter IV () and ATSAS program packages (). I0, Dmax and Rg were determined from P(r), although the Guinier approach was also used for comparison. The molecular weight of the species in solution was determined from I0.
Solutions of full-length ANXA11 were measured at protein concentrations of 3.8, 3.0, 1.9 mg/mL (70.0, 55.3, 35.0 µM) in the absence of calcium and at 3.6, 2.6 and 1.8 mg/mL (66.4, 47.9, 33.2 µM) in the presence of calcium (500 µM). Interparticle interactions were seen at higher concentrations. The curves were extrapolated to 0 and scale-merged using the PRIMUS software. Ab initio models were constructed using the programs DAMMIN (), DAMMIF () and GASBOR (). DAMMIN and its reimplementation DAMMIF represent the protein molecule by compact beads connected to each other. In GASBOR, proteins are represented as an ensemble of dummy residues instead of dummy atoms. The crystal structure of rat ANXA11 (6tu2) as a monomer was fitted manually into the GASBOR bead-model to observe the volume occupied by the N- and C-terminus. Molecular ensemble models were generated by the Ensemble Optimization Method (EOM) software (; ). This package generates an ensemble of protein conformations and a theoretical average scattering intensity curve based on the ensemble. Finally, it fits the theoretical curve onto the experimental SAXS data. High-resolution structures of individual protein domains can be used as rigid bodies, while intrinsically disordered protein segments are modelled with completely random configurations. The RANCH, FFMAKER and GAJOE programs, all available at https://www.embl-hamburg.de/biosaxs/, allow respectively generation of an ensemble of models, computation of the scattering intensities based on PDB structures, and the selection of the ensemble of conformations whose computed scattering curve best-fits the experimental SAXS curve. We separated the sequence of ANXA11 to an N-terminal (chain B) disordered region and a C-terminal globular domain (chain A). The C-terminal part was fixed as rigid body using the PDB file 6tu2 as a monomer. The last residue of the N terminus was kept in steric proximity of the first residue of the C-terminus by defining a 5–7 Å distance constraint between them. The input scattering curves were extrapolated to 0 concentration in the absence and presence of calcium. The raw data were deposited to the SASBDB database with accession codes SASDTV5 (apo) and SASDTW5 (holo).
Results
The N-terminal domain is intrinsically disordered
We produced the recombinant N-terminal domain of ANXA11 by E. coli expression of a fusion protein with an N-terminal thioredoxin tag. Since attempts to cleave the tag led to quantitative precipitation of the protein, we decided to keep the tag and analyze the fusion protein by NMR. The spectrum of this 15N-labelled protein showed a good dispersion but with a large number of resonances overlapping in the center of the spectrum (Figure 1). Comparison of the spectrum with the spectral assignment of thioredoxin retrieved from the BMRB data base (27636) allowed us to establish that the vast majority of the resonances with good chemical shift spreading correspond to residues in the thioredoxin tag, indicating that the residues of the ANXA11 N-terminus mainly contribute to the spectrum by the overlapping resonances. Absence of appreciable shifts of the thioredoxin peaks from their positions in the isolated protein indicated lack of significant interactions between the two proteins. This observation tells us that the ANXA11 N-terminus is mostly unstructured, as expected from the sequence composition.
FIGURE 1
Synthetic peptides have intermediate features between random coil and helical structures
We then analyzed the structure of the region 38–59 using synthetic peptides: we used a peptide spanning the sequence of wild-type ANXA11 (hereafter referred to as WT) and three peptides in which the clinically important mutations G38R and D40G were introduced. These mutants are hereafter indicated as G38R and D40G peptides. We screened different pH, temperatures, and buffer conditions by far-UV CD to understand how they could affect the WT peptide. When the peptide was dissolved in 10 mM phosphate buffer, it gave a CD spectrum with a negative minimum in ellipticity at 200 nm (Figure 2). This behavior is typical of an unfolded conformation. However, the spectrum also had a weak negative band around 220 nm which was compatible with a residual helical structure in equilibrium with a random coil conformation in the CD time scale (native helix) (). Changes in temperature and buffer/pH did not significantly affect the amount of secondary structure of the peptide. The K2D3 webserver () estimated 3%–6% α-helical and 15%–17% beta strand content. When 1%–30% (v/v) trifluoroethanol (TFE) was added, the minimum at 223 nm became deeper, corresponding to an appreciable increase in the propensity to a helical secondary structure. This alcohol is known to stabilize helical structure in peptides and is often used to enhance their helical propensities (). The G38R and D40G mutant peptides did not show appreciable differences to the WT. These results support the hypothesis of a helical element in this region of the ANXA11 N-terminus.
FIGURE 2
The 38–59 region has a strong helical tendency as observed by NMR
CD spectroscopy is an excellent technique to screen conditions, but NMR is a much more powerful means as it works in a different average time scale and can provide sequence-specific information on the structure of peptides. We thus studied the structural behavior of the peptides by NMR. Virtually complete assignment of the NMR spectrum of the non-labelled WT peptide in aqueous buffer was obtained using standard 2D techniques (; ), except for the highly mobile and solvent exchangeable first and second N-terminal residues. Numerous Nuclear Overhauser Effects (NOEs) were observed that are typical of an α-helical conformation. This is unusual for a peptide of this relatively small size in aqueous solutions, even more at neutral pH and without the addition of co-solvents. In particular, an almost uninterrupted network of sequential HN-HN effects was observed along the whole sequence (region L39-N69) (Figure 3). This behavior indicated a strong tendency of the peptide to fold in a helical conformation throughout the sequence and confirmed an overall behavior typical of a nascent helix (). The 10 lowest energy models of the WT peptide obtained by CS-Rosetta, a structure prediction program that uses chemical shift information, contained flexible termini (residues 37–38, 66–69), two distinct alpha-helices (residues 39–47, 52–65) and a short turn connecting the helices. This prediction does not however reflect the uninterrupted NH-NH sequential NOE cross-peak pattern. Accordingly, no long-range NOEs characteristic for a hairpin-like structure was identified. A plot of the secondary chemical shifts of the Hα of the peptides as defined by , a simple but effective method to detect secondary structural tendencies, suggested an uninterrupted helical structure for the isolated peptide. Conversely, extensive restrained and unrestrained molecular dynamics simulations provided trajectories with only transient formation of local helical regions, in agreement with the transient nature of a native helix (Supplementary Figure S3). Taken together, these results indicate that the peptides have a uniform tendency along the sequence to fold as a helix, but this secondary structure is not stably formed in water in the absence of stabilizing tertiary contacts.
FIGURE 3
When we analyzed the mutants, only minor chemical shift differences were observed at and around the residues affected by the mutations. Accordingly, the overall NOE patterns remained unchanged, indicating that the mutations do not affect the peptide structure and thus suggesting that D40 has a functional role. This is in agreement with the observation that the D40G mutation abolishes calcyclin binding (
Structural predictions of the full-length protein
To gain more information on the full-length protein, we first consulted AlphaFold (
FIGURE 4

Structural predictions of ANXA11 by RosETTAFold and AlphaFold. (A) The best-score prediction from AlphaFold (left), a bundle of the best-score predictions (middle), and a plot of the score confidence (pLDDT) versus the amino acid sequence (right). Values of pLDDT >90 indicate a model with high accuracy; values 70 to 90 a generally good backbone prediction; 50 to 70 low confidence, and <50 not reliable. (B) The best-score prediction from RosETTAFold (left), bundle of the best-score predictions (middle), and error estimate (right). The two plots provide a different but complementary version of the prediction reliability. In both sets of models, the reliability of the C-terminus is high, reflecting the level of conservation, whereas the N-terminal domain has much lower reliability.
The predictions by the two servers are different but have one feature in common (Figure 4B): all models predict an overall disordered structure for the N-terminus with a helix around residues 38–59. In the Alphafold structures, the helix tends to be interrupted around residues 47–49, whereas in the RosETTAFold structures the helix is uninterrupted. In the AlphaFold structures, the N-terminus consistently wraps around the C-terminal domain creating a more globular, though expanded, structure with the possibility of making contacts also between the region 38–59 and the first two annexin repeats. In the RosETTAFold structures, the N-terminus is completely separated from the C-terminus and does not form interactions with it.
SAXS suggests a conformational ensemble dominated by more globular species
SAXS is a low-resolution structural technique which can provide information about overall shape and domain orientation of proteins and is well suited to investigating flexible or intrinsically disordered proteins (
TABLE 1
| Data-collection parameters | |
|---|---|
| Instrument | ESRF BM29 |
| Wavelength (Å) | 0.99 |
| q-range (Å−1) | 0.007–0.5 |
| Sample-to-detector distance (m) | 2.8 |
| Concentration range (mg/mL) | 1–4 |
| Temperature (K) | 293 |
| Detector | Pilatus P3-2M |
| Flux (photons/s) | 1a1013 |
| Beam size (µm) | 500a200 |
| Structural parameters (absence of Ca2+) | 3.8 mg/mL | 3.0 mg/mL | 1.9 mg/mL | 0 mg/mL, extrapolated |
|---|---|---|---|---|
| I0 (kDa) [from Guinier] | 2.4 | 1.7 | 0.9 | 1.9 |
| I0 (kDa) [from real space] | 2.3 | 1.6 | 0.9 | 1.9 |
| Rg (Å) [from Guinier] | 42.5 ± 0.7 | 40.8 ± 0.7 | 37.3 ± 0.7 | 35.5 ± 0.7 |
| Rg (Å) [from real space]a | 44.8 | 41.5 | 38.7 | 38.4 |
| qmin—qmax used for Guinier (Å−1) | 1.2 × 10−2–3.1 × 10−2 | 8.3 × 10−3–3.2 × 10−2 | 8.9 × 10−3–3.5 × 10−2 | 6.8 × 10−3–3.7 × 10−2 |
| Volume (Å3) real space | 1.1 × 105 | 1.0 × 105 | 9.9 × 104 | 9.8 × 104 |
| Dmax (Å)a | 172.5 | 166.0 | 142.0 | 154.5 |
| Calculated MW (kDa) | 74 | 67 | 64 | 63 |
| Calculated theoretical MW monomer (kDa) | 54 | 54 | 54 | 54 |
| Structural parameters (presence of Ca2+) | 3.6 mg/mL | 2.6 mg/mL | 1.8 mg/mL | 0 mg/mL, extrapolated |
|---|---|---|---|---|
| I0 (kDa) [from Guinier] | 2.4 | 1.5 | 0.9 | 2.0 |
| I0 (kDa) [from real space] | 2.1 | 1.4 | 0.8 | 1.8 |
| Rg (Å) [from Guinier] | 43.6 ± 1.0 | 40 ± 0.8 | 38.94 ± 0.6 | 37.52 ± 0.6 |
| Rg (Å) [from real space]a | 43.6 | 41.5 | 38.1 | 38.0 |
| qmin—qmax used for Guinier (Å-1) | 1.1 × 10−2–3.0 × 10−2 | 1.3 × 10−2–3.2 × 10−2 | 6.8 × 10−3–3.4 × 10−2 | 7.3 × 10−3–3.5 × 10−2 |
| Volume (Å3) real space | 1.0 × 105 | 1.0 × 105 | 9.4 × 104 | 9.5 × 104 |
| Dmax (Å)a | 172.0 | 166.0 | 140.0 | 150.0 |
| Calculated MW (kDa) | 66 | 65 | 61 | 61 |
| Calculated theoretical MW monomer (kDa) | 54 | 54 | 54 | 54 |
| Software employed | |
|---|---|
| Primary data reduction | BM29 autoprocessing pipeline |
| Data processing | Scatter IV, PRIMUS, DAMMIN, DAMMIF, GASBOR, EOM |
Summary of the SAXS paramaters.
Uncertainties are not given by the program Scatter IV.
The log I(q) versus q curves showed a high degree of similarity at low q, with the holo form having a slightly larger Rg. A small deviation was seen at high q (Figure 5A and Supplementary Figure S4) that is consistent with small changes in buffer matching. The main peak of the normalized Kratky plots has an approximately gaussian shape that indicates a globular, elongated domain, whereas the tail suggests an unfolded region (Figure 5B), as explained in more detail below. Pair-distribution curves for the holo and apo forms showed a similar bell-shape with elongated tails with an increased Dmax 154.5 ± 0.5 Å for the apo form as compared with 150 ± 0.5 Å with the holo form. The computed distance distribution functions P(r) displayed a single peak with a tail, a pattern that is typical of proteins with elongated shapes (Figure 5C).
FIGURE 5

SAXS analysis and ab initio model of full-length ANXA11 in the presence and absence of calcium. (A) Plot of the Log10 SAXS intensity versus scattering vector, q. Dark blue: ANXA11 in the absence of calcium. Dark red: ANXAA11 in the presence of 500 µM calcium extrapolated to 0 mg/mL protein concentration. (B) Dimensionless Kratky plot. Cross-hair marks the Guinier-Kratky point (1.7, 1.1), the main peak position for globular particles. (C) Pair-distance function, P(r). The maximum dimension, Dmax, is the largest non-negative value that supports a smooth distribution function. (D) GASBOR ab initio models from scattering curves extrapolated to 0 concentration.
Shape reconstruction of full-length ANXA11 was performed by ab initio modelling using two complementary programs, DAMMIN (
The flexibility of the N-terminus was further investigated using two different approaches. For a qualitative approach, we used the normalized Kratky plot (Figure 5B) (
FIGURE 6

EOM analysis. (A, B) Fitting of an averaged theoretical scattering intensity derived from an ensemble of conformations using EOM (black) to experimental SAXS data extrapolated to 0 mg/mL protein concentration (blue: in the absence of calcium, red: 500 µM in the presence of calcium). (C, D) Plot of Rg distributions from EOM analysis, pool frequency (grey) and selection frequency (blue and red, absence and presence of calcium, respectively).
Altogether, these results tell us that there is little difference between the structures of the apo and holo forms of ANXA11, suggesting that calcium regulation does not involve major conformational changes between the calcium free and calcium loaded forms. This is in agreement with what is observed in other members of the annexin family with a much shorter N-terminus (
Functional peculiarities of the N- and C-termini of ANXA11
Finally, we analyzed the question of which region(s) of ANXA11 is/are involved in soluble (liquid-to-liquid) phase separation and in RNA-binding. We assessed the potential of ANXA11 to form protein granules using the catGRANULE approach (
The catGRANULE analysis indicated a strong propensity for granule formation, predominantly localized within the first ∼200 N-terminal residues, with limited contribution from the remainder of the protein (Figures 7A, B). This finding aligns with recent research proposing that the N-terminus is both necessary and sufficient for driving concentration-dependent ANXA11 phase transitions from dispersion to condensation (
FIGURE 7

Sequence-specific prediction of the tendency of ANXA11 to promote liquid-liquid phase separation and bind to RNA. (A) catGranule profile of the tendency to have phase transitions having a basic minimum threshold of 0.0 for phase transition propensity. (B) Plot of cumulative distribution function (CDF) as a function of the propensity score. CDF describes the probability of a random variable having values less than or equal to x. It is a cumulative function that sums together the total likelihood of an event up to that point. Its output ranges between 0 and 1. (C) catRAPID profile that predicts the tendence of full-length ANXA11 to bind RNA along its sequence. A horizontal line indicates the threshold for RNA binding. Note that each position on the x-axis corresponds to +/− 25 amino acids. Vertical lines help locating the positions along the sequences of the three higher peak maxima. The last maximum above the threshold contains a sequence semi-conserved in other annexins (indicated in the onset) that has been proven to be involved in RNA binding (
To complement these findings, we conducted an analysis with the catRAPID signature program, which predicts RNA-binding regions within a protein sequence. catRAPID signature leverages physicochemical properties, secondary structure characteristics, and hydrophobicity profiles (
These results point towards a primary role of ANXA11 N-terminus in granule formation, primarily triggered by structural disorder rather than RNA binding.
Discussion
We have studied the structure of ANXA11, an underexplored member of the annexin family. Discovered in the nineties (
We first showed direct evidence that the N-terminus is intrinsically disordered. Our data are independently supported by an archive preprint which draws the same conclusion on the full-length protein (
We then resorted to SAXS, a technique that, albeit at low resolution, provides information on the general features of a protein structure, to characterize the overall shape of ANXA11. SAXS has also been successfully used to define the conformational ensembles of intrinsically disordered proteins (
In a comprehensive preliminary paper, it was shown that the N-terminal domain is necessary and sufficient to promote liquid-liquid phase separation of the whole molecule which incorporates RNA into granules while interacting at the same time with lysosomes in a calcium-dependent way (
While more extensive testing is required to clarify this important aspect, it seems safe to say that the N-terminal domain of ANXA11 is an excellent example of a bona fide intrinsically disordered domain in which disorder is essential for the formation of phase transition probably co-adjuvated by protein-protein interactions.
Statements
Data availability statement
The datasets presented in this study can be found in the online repository SASBDB with accession codes SASDTV5 and SASDTW5.
Author contributions
ED: Investigation, Validation, Writing–review and editing, Data curation, Visualization. TF: Data curation, Investigation, Validation, Visualization, Writing–review and editing, Methodology. MT: Data curation, Methodology, Validation, Writing–review and editing, Formal Analysis, Supervision. GK: Data curation, Formal Analysis, Methodology, Supervision, Writing–review and editing. GT: Data curation, Formal Analysis, Investigation, Methodology, Software, Validation, Writing–review and editing.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. AP was recipient of Grants from the Dementia Research Initiative (RE1 3556) which is funded by the Medical Research Council, Alzheimer’s Society, and Alzheimer’s Research United Kingdom, and from ARUK (ARUK-PG2019B-020). ED acknowledges financial support from ESRF. This work was supported by the Francis Crick Institute through provision of access to the MRC Biomedical NMR Centre. The Francis Crick Institute receives its core funding from Cancer Research United Kingdom (FC001029), the United Kingdom Medical Research Council (FC001029), and the Wellcome Trust (FC001029).
Acknowledgments
We wish to thank Salvatore Adinolfi of University of Turin (Italy) and Boris Rogelj from the Jožef Stefan Institute, Ljubljana (Slovenia) for the annexin clones and Fabrizio Dal Piaz of University of Salerno (Italy) for the MS experiments on the annexin N-terminus. We are deeply indebted with Walter Chazin and with Montserrat Soler Lopez for helpful discussions and guidance. The authors also acknowledge use of the computing facility at King’s College London, Rosalind (https://rosalind.kcl.ac.uk), which is delivered in partnership with the National Institute for Health Research Biomedical Research Centres at South London and Maudsley and Guy’s and St. Thomas’ NHS Foundation Trusts, and part-funded by capital equipment grants from the Maudsley Charity (award 980) and Guy’s and St. Thomas’ Charity (TR130505).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmolb.2024.1347741/full#supplementary-material
References
1
AllainF.MareuilF.MénagerH.NilgesM.BardiauxB. (2020). ARIAweb: a server for automated NMR structure calculation. Nucleic Acids Res.48 (W1), W41–W47. 10.1093/nar/gkaa362
2
AukrustI.HollåsH.StrandE.EvensenL.TravéG.FlatmarkT.et al (2007). The mRNA-binding site of annexin A2 resides in helices C-D of its domain IV. J. Mol. Biol.368 (5), 1367–1378. 10.1016/j.jmb.2007.02.094
3
BabuM.FavrettoF.RankovicM.ZweckstetterM. (2022). Peptidyl prolyl isomerase A modulates the liquid–liquid phase separation of proline-rich IDPs. J. Am. Chem. Soc.144 (35), 16157–16163. 10.1021/jacs.2c07149
4
Bandorowicz-PikulaJ.KirilenkoA.van DeursenR.GolczakM.KühnelM.LancelinJ. M.et al (2003). A putative consensus sequence for the nucleotide-binding site of annexin A6. Biochemistry42 (30), 9137–9146. 10.1021/bi034359m
5
BernadoP.MylonasE.PetoukhovM. V.BlackledgeM.SvergunD. I. (2007). Structural characterization of flexible proteins using small-angle X-ray scattering. J. Am. Chem. Soc.129 (17), 5656–5664. 10.1021/ja069124n
6
BharadwajA.BydounM.HollowayR.WaismanD. (2013). Annexin A2 heterotetramer: structure and function. Int. J. Mol. Sci.14 (3), 6259–6305. 10.3390/ijms14036259
7
BolognesiB.Lorenzo GotorN.DharR.CirilloD.BaldrighiM.TartagliaG. G.et al (2016). A concentration-dependent liquid phase separation can cause toxicity upon increased protein expression. Cell Rep.16 (1), 222–231. 10.1016/j.celrep.2016.05.076
8
BrangwynneC. P.KoenderinkG. H.MacKintoshF. C.WeitzD. A. (2009). Intracellular transport by active diffusion. Trends Cell Biol.19 (9), 423–427. 10.1016/j.tcb.2009.04.004
9
BrownR. H.Al-ChalabiA. (2017). Amyotrophic lateral sclerosis. N. Engl. J. Med.377 (2), 162–172. 10.1056/NEJMra1603471
10
BrungerA. T. (2007). Version 1.2 of the crystallography and NMR system. Nat. Protoc.2 (11), 2728–2733. 10.1038/nprot.2007.406
11
BrüngerA. T.AdamsP. D.CloreG. M.DeLanoW. L.GrosP.Grosse-KunstleveR. W.et al (1998). Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D. Biol. Crystallogr.54 (Pt 5), 905–921. 10.1107/s0907444998003254
12
BurgerA.BerendesR.LiemannS.BenzJ.HofmannA.GöttigP.et al (1996). The crystal structure and ion channel activity of human annexin II, a peripheral membrane protein. J. Mol. Biol.257 (4), 839–847. 10.1006/jmbi.1996.0205
13
CasonS. E.HolzbaurE. L. F. (2022). Selective motor activation in organelle transport along axons. Nat. Rev. Mol. Cell Biol.23 (11), 699–714. 10.1038/s41580-022-00491-w
14
CordeiroT. N.Herranz-TrilloF.UrbanekA.EstañaA.CortésJ.SibilleN.et al (2017). Small-angle scattering studies of intrinsically disordered proteins and their complexes. Curr. Opin. Struct. Biol.42, 15–23. 10.1016/j.sbi.2016.10.011
15
DelaglioF.GrzesiekS.VuisterG. W.ZhuG.PfeiferJ.BaxA. (1995). NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR6 (3), 277–293. 10.1007/BF00197809
16
de Souza FerreiraL. P.da SilvaR. A.GilC. D.GeisowM. J. (2023). Annexin A1, A2, A5, and A6 involvement in human pathologies. Proteins91 (9), 1191–1204. 10.1002/prot.26512
17
DurandD.VivesC.CannellaD.PerezJ.Pebay-PeyroulaE.VachetteP.et al (2010). NADPH oxidase activator p67(phox) behaves in solution as a multidomain protein with semi-flexible linkers. J. Struct. Biol.169 (1), 45–53. 10.1016/j.jsb.2009.08.009
18
DysonH. J.RanceM.HoughtenR. A.LernerR. A.WrightP. E. (1988a). Folding of immunogenic peptide fragments of proteins in water solution. I. Sequence requirements for the formation of a reverse turn. J. Mol. Biol.201 (1), 161–200. 10.1016/0022-2836(88)90446-9
19
DysonH. J.RanceM.HoughtenR. A.WrightP. E.LernerR. A. (1988b). Folding of immunogenic peptide fragments of proteins in water solution. II. The nascent helix. J. Mol. Biol.201 (1), 201–217. 10.1016/0022-2836(88)90447-0
20
FalliniC.Donlin-AspP. G.RouanetJ. P.BassellG. J.RossollW. (2016). Deficiency of the survival of motor neuron protein impairs mRNA localization and local translation in the growth cone of motor neurons. J. Neurosci.36 (13), 3811–3820. 10.1523/JNEUROSCI.2396-15.2016
21
FernandopulleM.WangG.Nixon-AbellJ.QamarS.BalajiV.MoriharaR.et al (2019). Inherited and sporadic amyotrophic lateral sclerosis and fronto-temporal lobar degenerations arising from pathological condensates of phase separating proteins. Hum. Mol. Genet.28 (R2), R187–R196. 10.1093/hmg/ddz162
22
FernandopulleM. S.Lippincott-SchwartzJ.WardM. E. (2021). RNA transport and local translation in neurodevelopmental and neurodegenerative disease. Nat. Neurosci.24 (5), 622–632. 10.1038/s41593-020-00785-2
23
FilipenkoN. R.MacLeodT. J.YoonC. S.WaismanD. M. (2004). Annexin A2 is a novel RNA-binding protein. J. Biol. Chem.279 (10), 8723–8731. 10.1074/jbc.M311951200
24
FrankeD.SvergunD. I. (2009). DAMMIF, a program for rapid ab-initio shape determination in small-angle scattering. J. Appl. Crystallogr.42 (Pt 2), 342–346. 10.1107/S0021889809000338
25
GerkeV.CreutzC. E.MossS. E. (2005). Annexins: linking Ca2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol.6 (6), 449–461. 10.1038/nrm1661
26
GerkeV.MossS. E. (2002). Annexins: from structure to function. Physiol. Rev.82 (2), 331–371. 10.1152/physrev.00030.2001
27
HellmanM.PiirainenH.JaakolaV. P.PermiP. (2014). Bridge over troubled proline: assignment of intrinsically disordered proteins using (HCA)CON(CAN)H and (HCA)N(CA)CO(N)H experiments concomitantly with HNCO and i(HCA)CO(CA)NH. J. Biomol. NMR58 (1), 49–60. 10.1007/s10858-013-9804-0
28
HongS.NaS.KimO. H.JeongS.OhB. C.HaN. C. (2020). High-resolution structures of annexin A5 in a two-dimensional array. J. Struct. Biol.209 (1), 107401. 10.1016/j.jsb.2019.10.003
29
HymanA. A.BrangwynneC. P. (2011). Beyond stereospecificity: liquids and mesoscale organization of cytoplasm. Dev. Cell21 (1), 14–16. 10.1016/j.devcel.2011.06.013
30
HymanA. A.WeberC. A.JülicherF. (2014). Liquid-liquid phase separation in biology. Annu. Rev. Cell Dev. Biol.30, 39–58. 10.1146/annurev-cellbio-100913-013325
31
JoS.KimT.IyerV. G.ImW. (2008). CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput. Chem.29 (11), 1859–1865. 10.1002/jcc.20945
32
JumperJ.EvansR.PritzelA.GreenT.FigurnovM.RonnebergerO.et al (2021). Highly accurate protein structure prediction with AlphaFold. Nature596 (7873), 583–589. 10.1038/s41586-021-03819-2
33
KachalaM.ValentiniE.SvergunD. I. (2015). Application of SAXS for the structural characterization of IDPs. Adv. Exp. Med. Biol.870, 261–289. 10.1007/978-3-319-20164-1_8
34
KanelisV.DonaldsonL.MuhandiramD. R.RotinD.Forman-KayJ. D.KayL. E. (2000). Sequential assignment of proline-rich regions in proteins: application to modular binding domain complexes. J. Biomol. NMR16 (3), 253–259. 10.1023/a:1008355012528
35
KarjalainenM.TossavainenH.HellmanM.PermiP. (2020). HACANCOi: a new Hα-detected experiment for backbone resonance assignment of intrinsically disordered proteins. J. Biomol. NMR74 (12), 741–752. 10.1007/s10858-020-00347-5
36
KatoM.McKnightS. L. (2018). A solid-state conceptualization of information transfer from gene to message to protein. Annu. Rev. Biochem.87, 351–390. 10.1146/annurev-biochem-061516-044700
37
KellerR. L. J. (2004). The computer aided resonance assignment tutorial. Centralstrasse 1, CH-6410 Goldau, Switzerland: CANTINA Verlag.
38
KiefferJ.BrennichM.FlorialJ. B.OscarssonM.De Maria AntolinosA.TullyM.et al (2022). New data analysis for BioSAXS at the ESRF. J. Synchrotron Radiat.29 (Pt 5), 1318–1328. 10.1107/S1600577522007238
39
LeeJ.ChengX.SwailsJ. M.YeomM. S.EastmanP. K.LemkulJ. A.et al (2016). CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J. Chem. Theory Comput.12 (1), 405–413. 10.1021/acs.jctc.5b00935
40
LeeW.TonelliM.MarkleyJ. L. (2015). NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy. Bioinformatics31 (8), 1325–1327. 10.1093/bioinformatics/btu830
41
LeeY. T.DimitrovaY. N.SchneiderG.RidenourW. B.BhattacharyaS.SossS. E.et al (2008). Structure of the S100A6 complex with a fragment from the C-terminal domain of Siah-1 interacting protein: a novel mode for S100 protein target recognition. Biochemistry47 (41), 10921–10932. 10.1021/bi801233z
42
LentonS.FagerbergE.TullyM.SkepöM. (2023). From dilute to concentrated solutions of intrinsically disordered proteins: interpretation and analysis of collected data. Methods Enzymol.678, 299–330. 10.1016/bs.mie.2022.09.021
43
LiaoY. C.FernandopulleM. S.WangG.ChoiH.HaoL.DrerupC. M.et al (2019). RNA granules Hitchhike on lysosomes for long-distance transport, using annexin A11 as a molecular tether. Cell179 (1), 147–164. 10.1016/j.cell.2019.08.050
44
LillebostadP. A. G.RaasakkaA.HjellbrekkeS. J.PatilS.RøstbøT.HollåsH.et al (2020). Structure of the ALS mutation target annexin A11 reveals a stabilising N-terminal segment. Biomolecules10 (4), 660. 10.3390/biom10040660
45
LiviC. M.KlusP.Delli PontiR.TartagliaG. G. (2016). catRAPID signature: identification of ribonucleoproteins and RNA-binding regions. Bioinformatics32 (5), 773–775. 10.1093/bioinformatics/btv629
46
Louis-JeuneC.Andrade-NavarroM. A.Perez-IratxetaC. (2012). Prediction of protein secondary structure from circular dichroism using theoretically derived spectra. Proteins80 (2), 374–381. 10.1002/prot.23188
47
MaciejewskiM. W.SchuylerA. D.GrykM. R.MoraruIIRomeroP. R.UlrichE. L.et al (2017). NMRbox: a resource for biomolecular NMR computation. Biophys. J.112 (8), 1529–1534. 10.1016/j.bpj.2017.03.011
48
Manalastas-CantosK.KonarevP. V.HajizadehN. R.KikhneyA. G.PetoukhovM. V.MolodenskiyD. S.et al (2021). ATSAS 3.0: expanded functionality and new tools for small-angle scattering data analysis. J. Appl. Crystallogr.54 (Pt 1), 343–355. 10.1107/S1600576720013412
49
Nixon-AbellJ.RuggeriF. S.QamarS.HerlingT. W.CzekalskaM. A.ShenY.et al (2023). ANXA11 biomolecular condensates facilitate protein-lipid phase coupling on lysosomal membranes. bioRxiv, 2023.03.22.533832. 10.1101/2023.03.22.533832
50
PastoreA.SaudekV. (1990). The relationship between chemical shift and secondary structure in proteins. J. Magnetic Reson.90(1), 165–176. 10.1016/0022-2364(90)90375-j
51
PatilS. S.PanchalV.RøstbøT.RomanyukS.HollåsH.BrenkR.et al (2023). RNA-binding is an ancient trait of the Annexin family. Front. Cell Dev. Biol.11, 1161588. 10.3389/fcell.2023.1161588
52
PhillipsJ. C.HardyD. J.MaiaJ. D. C.StoneJ. E.RibeiroJ. V.BernardiR. C.et al (2020). Scalable molecular dynamics on CPU and GPU architectures with NAMD. J. Chem. Phys.153 (4), 044130. 10.1063/5.0014475
53
RedfieldC. (1993). “Resonance assignment strategies for small proteins,” in NMR of macromolecules. Editor RobertG. C. K. (Oxford: Oxford University Press), 71–99.
54
RedpathG. M. I.AnanthanarayananV. (2023). Endosomal sorting sorted - motors, adaptors and lessons from in vitro and cellular studies. J. Cell Sci.136 (5), jcs260749. 10.1242/jcs.260749
55
RétyS.OsterlohD.AriéJ. P.TabariesS.SeemanJ.Russo-MarieF.et al (2000). Structural basis of the Ca(2+)-dependent association between S100C (S100A11) and its target, the N-terminal part of annexin I. Structure8 (2), 175–184. 10.1016/s0969-2126(00)00093-9
56
RiepingW.HabeckM.BardiauxB.BernardA.MalliavinT. E.NilgesM. (2007). ARIA2: automated NOE assignment and data integration in NMR structure calculation. Bioinformatics23 (3), 381–382. 10.1093/bioinformatics/btl589
57
Rintala-DempseyA. C.RezvanpourA.ShawG. S. (2008). S100-annexin complexes--structural insights. FEBS J.275 (20), 4956–4966. 10.1111/j.1742-4658.2008.06654.x
58
RosengarthA.LueckeH. (2003). A calcium-driven conformational switch of the N-terminal and core domains of annexin A1. J. Mol. Biol.326 (5), 1317–1325. 10.1016/s0022-2836(03)00027-5
59
RosengarthA.RösgenJ.HinzH. J.GerkeV. (2001). Folding energetics of ligand binding proteins II. Cooperative binding of Ca2+ to annexin I. J. Mol. Biol.306 (4), 825–835. 10.1006/jmbi.2000.4358
60
SalogiannisJ.Reck-PetersonS. L. (2017). Hitchhiking: a non-canonical mode of microtubule-based transport. Trends Cell Biol.27 (2), 141–150. 10.1016/j.tcb.2016.09.005
61
ShenY.LangeO.DelaglioF.RossiP.AraminiJ. M.LiuG.et al (2008). Consistent blind protein structure generation from NMR chemical shift data. Proc. Natl. Acad. Sci.105 (12), 4685–4690. 10.1073/pnas.0800256105
62
SmithB. N.ToppS. D.FalliniC.ShibataH.ChenH. J.TroakesC.et al (2017). Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Sci. Transl. Med.9 (388), eaad9157. 10.1126/scitranslmed.aad9157
63
SopkovaJ.Raguenes-NicolC.VincentM.ChevalierA.Lewit-BentleyA.Russo-MarieF.et al (2002). Ca(2+) and membrane binding to annexin 3 modulate the structure and dynamics of its N terminus and domain III. Protein Sci.11 (7), 1613–1625. 10.1110/ps.4230102
64
SvergunD. I. (1999). Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys. J.76 (6), 2879–2886. 10.1016/S0006-3495(99)77443-6
65
SvergunD. I.PetoukhovM. V.KochM. H. (2001). Determination of domain structure of proteins from X-ray solution scattering. Biophys. J.80 (6), 2946–2953. 10.1016/S0006-3495(01)76260-1
66
TeyssouE.MuratetF.AmadorM. D.FerrienM.LautretteG.MachatS.et al (2021). Genetic screening of ANXA11 revealed novel mutations linked to amyotrophic lateral sclerosis. Neurobiol. Aging99, 102.e11–102.e20. 10.1016/j.neurobiolaging.2020.10.015
67
TowleC. A.TreadwellB. V. (1992). Identification of a novel mammalian annexin. cDNA cloning, sequence analysis, and ubiquitous expression of the annexin XI gene. J. Biol. Chem.267 (8), 5416–5423. 10.1016/s0021-9258(18)42782-2
68
TravéG.PastoreA.HyvönenM.SarasteM. (1995). The C-terminal domain of alpha-spectrin is structurally related to calmodulin. Eur. J. Biochem.227 (1-2), 35–42. 10.1111/j.1432-1033.1995.tb20357.x
69
TriaG.MertensH. D.KachalaM.SvergunD. I. (2015). Advanced ensemble modelling of flexible macromolecules using X-ray solution scattering. IUCrJ2 (Pt 2), 207–217. 10.1107/S205225251500202X
70
TullyM. D.KiefferJ.BrennichM. E.Cohen AberdamR.FlorialJ. B.HutinS.et al (2023). BioSAXS at European Synchrotron Radiation Facility - extremely Brilliant Source: BM29 with an upgraded source, detector, robot, sample environment, data collection and analysis software. J. Synchrotron Radiat.30 (Pt 1), 258–266. 10.1107/S1600577522011286
71
TullyM. D.TarbouriechN.RamboR. P.HutinS. (2021). Analysis of SEC-SAXS data via EFA deconvolution and Scatter. J. Vis. Exp.167. 10.3791/61578
72
VaradiM.AnyangoS.DeshpandeM.NairS.NatassiaC.YordanovaG.et al (2022). AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic acids Res.50 (D1), D439–D444. 10.1093/nar/gkab1061
73
VedelerA.HollåsH. (2000). Annexin II is associated with mRNAs which may constitute a distinct subpopulation. Biochem. J.348 Pt 3 (Pt 3), 565–572. 10.1042/0264-6021:3480565
74
VedelerA.HollåsH.GrindheimA. K.RaddumA. M. (2012). Multiple roles of annexin A2 in post-transcriptional regulation of gene expression. Curr. Protein Pept. Sci.13 (4), 401–412. 10.2174/138920312801619402
75
VincenziM.MercurioF. A.LeoneM. (2019). About TFE: old and new findings. Curr. Protein Pept. Sci.20 (5), 425–451. 10.2174/1389203720666190214152439
76
WangA. C.GrzesiekS.TschudinR.LodiP. J.BaxA. (1995). Sequential backbone assignment of isotopically enriched proteins in D2O by deuterium-decoupled HA(CA)N and HA(CACO)N. J. Biomol. NMR5 (4), 376–382. 10.1007/BF00182281
77
WangX.WangD.ZhaoJ.QuM.ZhouX.HeH.et al (2006). The proline-rich domain and the microtubule binding domain of protein tau acting as RNA binding domains. Protein Pept. Lett.13 (7), 679–685. 10.2174/092986606777790566
78
WuthrichK. (1986). NMR of proteins and nucleic acids. New York: Wiley.
79
YangJ.AnishchenkoI.ParkH.PengZ.OvchinnikovS.BakerD. (2020). Improved protein structure prediction using predicted interresidue orientations. Proc. Natl. Acad. Sci. U. S. A.117 (3), 1496–1503. 10.1073/pnas.1914677117
80
ZaepfelB. L.RothsteinJ. D. (2021). RNA is a double-edged sword in ALS pathogenesis. Front. Cell Neurosci.15, 708181. 10.3389/fncel.2021.708181
81
ZhangX.VigersM.McCartyJ.RauchJ. N.FredricksonG. H.WilsonM. Z.et al (2020). The proline-rich domain promotes Tau liquid-liquid phase separation in cells. J. Cell Biol.219 (11), e202006054. 10.1083/jcb.202006054
Summary
Keywords
amyotrophic lateral sclerosis, annexins, intrinsically unstructured regions, NMR, small angle X-ray scattering, structure
Citation
Dudas EF, Tully MD, Foldes T, Kelly G, Tartaglia GG and Pastore A (2024) The structural properties of full-length annexin A11. Front. Mol. Biosci. 11:1347741. doi: 10.3389/fmolb.2024.1347741
Received
01 December 2023
Accepted
17 January 2024
Published
07 March 2024
Volume
11 - 2024
Edited by
Andrea Mozzarelli, University of Parma, Italy
Reviewed by
Rashmi Panigrahi, University of Alberta, Canada
Moriah Rene Beck, Wichita State University, United States
Updates

Check for updates
Copyright
© 2024 Dudas, Tully, Foldes, Kelly, Tartaglia and Pastore.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Annalisa Pastore, annalisa.1.pastore@kcl.ac.uk
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.